menu search

Should vanguard s&p small-cap 600 etf (vioo) be on your investing radar?

Launched on 09/09/2010, the Vanguard S&P Small-Cap 600 ETF (VIOO) is a passively managed exchange traded fund designed to provide a broad exposure to ...

October 23, 2023, 7:31 am

View chevron to buy hess corp for $53 bln in all-stock deal

Chevron Corp said on Monday it would buy smaller rival Hess Corp in a $53 billion all-stock deal, taking its rivalry with Exxon Mobil to the next leve...

October 23, 2023, 7:17 am

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...

October 23, 2023, 5:00 am

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...

October 23, 2023, 5:00 am

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...

October 23, 2023, 5:00 am

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...

October 23, 2023, 5:00 am

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...

October 23, 2023, 5:00 am

Converge technology: many doubts about the company, but it is very cheap

Converge provides IT services and solutions, including cloud computing, data center solutions, cybersecurity, advanced IT infrastructure, and software...

October 23, 2023, 4:29 am

Private banks tighten vigil on small unsecured loans

Mumbai: small loans may turn out to be a big worry for banks. Some lenders are seeing stress rise in sm...

October 23, 2023, 2:59 am

Astrazeneca gains european approval for lung cancer drug

AstraZeneca PLC (LSE:AZN) has announced that its jointly developed lung cancer drug has been approved for use in the European Union. Enhertu, which ha...

October 23, 2023, 2:57 am

Jack henry & associates: 'vertical' software is eating the world

Jack Henry & Associates is a software company that provides technology solutions for small banks and cr...

October 23, 2023, 12:27 am

Private banks tighten vigilance on small unsecured loans

Banks in India are seeing a rise in stress related to small unsecured personal loans as borrowers with ...

October 22, 2023, 11:29 pm

Dfsv: worth shortlisting, not a buy due to factor disadvantages

DFSV is a mostly solid small-cap echelon-focused actively managed ETF. As it frequently happens with funds looking promising on the surface, there are...

October 22, 2023, 11:06 pm

Revolution medicines presents promising clinical activity and safety data from phase 1/1b trial of rmc-6236

Investor Webcast to be held Sunday, October 22 at 12:30 p.m. Eastern Time REDWOOD CITY, Calif., Oct. 22, 2023 (GLOBE NEWSWIRE) — Revolution Medicine...

October 22, 2023, 6:30 am

Silver prices forecast: bullish wave amid geopolitical strife, short-covering

XAG/USD rises amid Middle East tension, showcasing trading divergence; rally fueled by short-covering, polarizing ...

October 22, 2023, 6:00 am

B2gold corp.'s golden horizons with growth footing

B2Gold Corp.: 5.0% dividend yield, strong cash position with significant investments in expansion. Major international events are unfolding, putting u...

October 22, 2023, 12:22 am

Bank7: great small bank gliding through crisis

Bank7 has demonstrated strong performance and increased deposits during the regional banking crisis, trading at an undervalued 1.3 times book value. T...

October 22, 2023, 12:06 am

8 best small-business loans for women of october 2023

7(a) program participants include specialized lenders like Live Oak Bank and big-name traditional banks like Wells Fargo. Read Full Story at source (m...

October 21, 2023, 7:29 pm

Top small business grants in wisconsin

Wisconsin has about 460,000 small business owners statewide who can apply for ...

October 21, 2023, 4:59 pm

Harpoon therapeutics announces updated interim tolerability and response data from phase 1/2 clinical trial of t cell engager hpn328 at esmo congress 2023

Confirmed response rate 35% (11/31), across all tumor types and patient cohorts treated with 1 mg priming dose, including three confirmed, complete re...

October 21, 2023, 3:31 pm


Search within

Pages Search Results: